Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies

Bone Marrow Transplant. 2021 Jul;56(7):1732-1736. doi: 10.1038/s41409-021-01241-w. Epub 2021 Mar 8.

Affiliations

¹ Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. [email protected].
² Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

PMID: 33686247
DOI: 10.1038/s41409-021-01241-w

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Hematologic Neoplasms* / therapy
Humans
L-Lactate Dehydrogenase
Retrospective Studies
Transplants*

Substances

L-Lactate Dehydrogenase